Cargando…
CRISPR-Cas9 in hiPSCs: A new era in personalized treatment for Stargardt disease
Autores principales: | Kuntam, Soujanya, Cingaram, Pradeep Reddy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236169/ https://www.ncbi.nlm.nih.gov/pubmed/37273783 http://dx.doi.org/10.1016/j.omtn.2023.05.008 |
Ejemplares similares
-
Efficient correction of ABCA4 variants by CRISPR-Cas9 in hiPSCs derived from Stargardt disease patients
por: Siles, Laura, et al.
Publicado: (2023) -
Dopaminergic differentiation of schizophrenia hiPSCs
por: Hartley, Brigham J., et al.
Publicado: (2015) -
ASSURED-optimized CRISPR protocol for knockout/SNP knockin in hiPSCs
por: Ludwik, Katarzyna A., et al.
Publicado: (2023) -
Editing the genome of hiPSC with CRISPR/Cas9: disease models
por: Bassett, Andrew R.
Publicado: (2017) -
Genetic Cardiomyopathies: The Lesson Learned from hiPSCs
por: My, Ilaria, et al.
Publicado: (2021)